我院2007-2010年抗乙型肝炎病毒核苷类药应用分析  

Analysis of the Utilization of Anti-HBV Nucleosides Drugs in Our Hospital from 2007 to 2010

作　　者：杨青[1] 罗淑萍[1] 卢华[1] 

机构地区：[1]广西壮族自治区人民医院,南宁市530021

出　　处：《中国药房》2011年第26期2431-2433,共3页China Pharmacy

摘　　要：目的:评价我院抗乙型肝炎病毒(HBV)核苷类药的应用现状及趋势。方法:采用回顾性方法,对我院2007-2010年抗HBV核苷类药的销售金额、用药频度和日均费用(DDC)等进行统计、分析。结果:我院抗HBV核苷类药销售金额呈逐年增长趋势,以2009年增幅最大,达130.81%;DDC逐年下降,但降幅不大。结论:我院抗HBV核苷类药应用正逐步规范化。OBJECTIVE：To evaluate the status quo and tendency of the utilization of anti-HBV nucleosides drugs in our hospital. METHODS： By retrospective method, the utilization anti-HBV nucleosides drugs in our hospital from 2007 to 2010 were analyzed statistically in respect of consumption sum, DDDs and DDC. RESULTS：The consumption sum of anti-HBV nucleosides drugs in our hospital increased year by year, with 2009 witnessed the highest increase of 130.81%. DDC had decreased with little range year by year. CONCLUSION：The utilization of anti-HBV nucleosides drugs in our hospital is getting more and more standard.

关 键 词：抗乙型肝炎病毒核苷类药 用药频度 日均费用 销售金额 

分 类 号：R969.3[医药卫生—药理学] R287[医药卫生—药学]